Health and Healthcare

Monday's Top Biotech & Medical Stocks

From BioHealth Investor

Biotechnology

ORAGENICS INC [ONI] +12.51%
GTX, INC. [GTXI] +8.83%
XTL BIOPHARMACEUTICA [XTLB] +7.83%
CRITICAL THERAPEUTIC [CRTX] +7.27%
OMRIX BIOPHARMACEUTI [OMRI] +6.77%

Diagnostic Substances

HEALTHCARE TECH LTD [HCTL] +9.16%
OSTEOLOGIX INC [OLGX.OB] +6.84%
AVANT IMMUNOTHERAP [AVAN] +4.73%
SYNOVICS PHARMACEUTL [SYVC.OB] +4.00%
ASPENBIO PHARMA INC [APNB.OB] +3.60%

Drug Delivery

SYMBOLLON PHARM CL A [SYMBA.OB] +4.55%
SKYEPHARMA PLC [SKYE] +4.51%
COLUMBIA LABS INC [CBRX] +4.29%
NOVEN PHARMACEUTIC [NOVN] +1.29%
MATRIXX INITIATVS [MTXX] +0.55%

Drug Manufacturers

SCICLONE PHARMA [SCLN] +9.18%
ALTAIR NANOTECH INC [ALTI] +4.86%
JAVELIN PHARMACEUTIC [JAV] +4.14%
BRADLEY PHARMACTCL [BDY] +4.04%
ABRAXIS BIOSCIENCE [ABBI] +4.01%

Medical Appliances & Equipment

MEDICALCV INC [MCVI.OB] +13.64%
VNUS MEDICAL TECHNOL [VNUS] +7.71%
CELSION CORP [CLN] +5.92%
LANGER INC [GAIT] +5.39%
ATS MEDICAL INC [ATSI] +3.03%

Medical Instruments & Supplies

OCCULOGIX, INC. [OCCX] +7.89%
ROCHESTER MEDICAL [ROCM] +6.31%
ENCISION INC [ECI] +3.76%
STRATEGIC DIAGNOST [SDIX] +3.50%
STEN CORPORATION [STEN] +3.02%

Medical Laboratories & Research

MEDASORB TECHNOLOGS [MSBT.OB] +2.17% $0
RADNET INC [RDNT] +1.43% $0
NEOGENOMICS INC [NGNM.OB] +1.32% $0
PSYCHEMEDICS NEW [PMD] +0.83% $75.0 M
ERESEARCHTECHNOLOG [ERES] +0.67%

http://www.biohealthinvestor.com/

Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)

Take the quiz below to get matched with a financial advisor today.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the
advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future

Take the retirement quiz right here.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.